Guidance

Cox-2 selective inhibitors and non-steroidal anti-inflammatory drugs’ (NSAIDs): Cardiovascular safety

Guidance on the cardiovascular safety of Cox-2 inhibitors and NSAIDs and further reading.

• From: Medicines and Healthcare products Regulatory Agency
• Published: 2 January 2015

Applies to England, Scotland and Wales

Documents

Cox-2 selective inhibitors and non-steroidal anti-inflammatory drugs (NSAIDs): Cardiovascular safety

HTML

Details

Medicines and Healthcare products Regulatory Agency guidance for healthcare professionals on the cardiovascular safety of Cox-2 inhibitors and NSAIDs including safety reviews carried out.

Published 2 January 2015